Utilizing Erythrocyte Lifespan as a Predictor for Moderate to Severe Anemia in Patients with Advanced Gastric Cancer Following Anti-Tumor Treatments: A Prospective Investigation

• by Xiurong Yu, Liyu Su, Rong Lu, Shen Zhao, Rongbo Lin, Xianren Ye

• November 19, 2025

A Comprehensive Review of Monoclonal Gammopathy of Undetermined Significance

Approximately 3% to 4% of the population over the age of 50 is diagnosed with monoclonal gammopathy of undetermined significance (MGUS). It carries a lifelong risk of progression to multiple myeloma and lymphoma, requiring risk-adapted monitoring by multidisciplinary teams.

• by Kimberly Noonan, Kevin Brigle, Charise Gleason, Carrie Bellerive, Mary Steinbach, Deborah Doss

• March 4, 2026

• 17 min

CRISPR Therapy Raises Fetal Hemoglobin in Sickle Cell Disease

An investigational Cas12a-edited stem cell treatment sharply boosted HbF and largely eliminated vaso-occlusive crises in an early trial

• April 13, 2026

• 2 min

Warning Signs of Hematologic Malignancies in the Primary Care Setting

Eunice Wang, MD, Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center, offers guidance on what red flags may indicate a hematologic cancer in your patients to help you identify these complex and often difficult-to-treat cancers as early as possible.

• March 22, 2021

• 1 min